IMPORTANT- We are requiring all individuals that enter our clinic to wear a properly fitting face mask.
We are now accepting payments online through our patient portal.
Click on the title to see the full article:
A long-term safety and efficacy study of trifarotene 50µg g cream in subjects with facial and truncal acne
A Multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance therapy
A Randomized, Parallel, Vehicle-Controlled Comparison of Two Erythromycin Benzoyl Peroxide Preparations for Acne Vulgaris
A triple combination agent in the treatment of melasma
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris
Assessing efficacy of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) in aqueous gel in moderate of severe acne subpopulations
Assessing efficacy of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) in aqueous gel in the treatment of severe acne
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne
Hormonal Contraceptives for Acne Management
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea
Currently Recruiting Studies:
(2 to 17 years of age)
(2 and over)
(18 and over)
Call our new research patient line to see if you qualify!
(503) 222 - SKIN
Oregon Dermatology & Research Center - 2565 NW Lovejoy St., Portland, OR, 97210 - (503) 226-3376.